Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
Once the rain exits Friday night, it remains breezy through Saturday, but at least the sun comes back out. The next day to watch for potentially impactful weather is Sunday. Much of the day stays ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility ... inspection from December 4 to 15, 2023, Sun Pharma disclosed the classification status ...
Friday, 12 members of an FDA advisory committee voted unanimously ... patients with multiple myeloma,” the company told Fierce Pharma a few days ahead of the Friday meeting.
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Royalty Pharma plc (Symbol: RPRX) entered into oversold territory, hitting an RSI reading of ...
Image Source : FILE Business stock exchange building. In today’s trading session, the Indian stock market witnessed a decline, with the Sensex plummeting by 250 points and the Nifty slipping ...
After investigations into the FDA’s response to severe drug shortages and other issues, the House Committee on Oversight and Accountability finally had its long-awaited chance to grill the ...
From the Sensex pack, NTPC, L&T and Mahindra and Mahindra were among the major gainers in the morning session whereas, Sun Pharma, HCL and Infosys were among the laggards. The Indian rupee opened ...
At this price, the company commanded a market capitalisation (m-cap) of Rs 57,038.9 crore. Sun Pharma Advanced Research Company Ltd shares slumped 4.99% to close at Rs 408.25. The company's m-cap ...
Increased import costs are part of the problem. The U.S. is the largest goods importer in the world, bringing in $3.2 trillion in 2022. Import costs rose dramatically in 2021 and 2022 due to ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...